HOME ONGOING PHASE IV RESEARCH Cardiovascular and renal treatment in heart failure patients with hyperkalemia or at high risk of hyperkalemia Nephrology and Rare Diseases Hyperkalemia Go to Clinicaltrials.gov Study summary Study type: Observational [Patient Registry] Study identification number: NCT04864795 Recruitment status: Recruiting Estimated enrollment: Up to 5,000 participants Actual study start date: 19 April 2021 Estimated study completion date: May 2025 Contact details medinfo@viforpharma.com